Results 221 to 230 of about 582,867 (329)
What's New? Mismatch repair deficiency (dMMR) in rectal cancer is rare, and knowledge about tumor biological behavior, response to treatment, and clinical outcomes in this subset of patients is limited. This nationwide cohort study including 182 patients with dMMR rectal cancer found that they were younger and had more poorly differentiated tumors ...
Renee A. Lunenberg +14 more
wiley +1 more source
Rectal metastasis as the initial presentation of primary lung adenocarcinoma with an EGFR L858R mutation: a case report. [PDF]
Nian R +8 more
europepmc +1 more source
What's New? Prognostic assessment in metastatic colorectal cancer (mCRC), which is currently based on scores derived from clinical trials, requires refinement to enhance treatment outcomes and quality of care. In this study, the authors evaluated real‐world data from the German tumor registry to prospectively validate a modified mCRC prognostic score ...
Karin Potthoff +19 more
wiley +1 more source
Linked color imaging for detection and characterization of gastrointestinal neuroendocrine tumors. [PDF]
Pu X +5 more
europepmc +1 more source
Claudin expression in rectal well-differentiated endocrine neoplasms (carcinoid tumors)
Okabe
openalex +2 more sources
What's New? Chemoradiotherapy is the standard treatment for squamous cell carcinoma of the anus (SCCA). Toxicities linked to chemoradiotherapy, however, can negatively impact the quality of life, and biomarkers to distinguish which patients will benefit from treatment are lacking.
Anne Vittrup Jakobsen +4 more
wiley +1 more source
Tumores Neuroendócrinos do reto: do diagnóstico à terapêutica [PDF]
Narcisa Flôr Rodrigues Pinto Guimarães
core
Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. [PDF]
A C Wagner +17 more
core +1 more source

